Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.
about
Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalKinase inhibitors as potential agents in the treatment of multiple myeloma.Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin.Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.Alterations in Hoffa's fat pad induced by an inflammatory response following idealized anterior cruciate ligament surgery.The Potential of Angiogenin as a Serum Biomarker for Diseases: Systematic Review and Meta-Analysis.Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model.
P2860
Q26853543-90D8251F-A25B-4071-B5AF-05EE6887F74BQ37697253-ED0887F4-A1BB-4912-A97A-2EF998E0FE83Q38588911-5C9722E3-8DCF-4C4B-9C13-6204D3A38360Q45756098-DBCAB092-0A66-434B-A259-A64C192E7528Q53462019-A40C44D8-CE69-43C6-A7E4-E3D512162B3AQ54939127-73A122C5-9B70-4E2E-96D3-76F6497CCA95Q55097633-91E65E77-F19A-48A7-BD01-E5C0687E5478
P2860
Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Emerging roles of endoglin/CD1 ...... in multiple myeloma patients.
@en
Emerging roles of endoglin/CD1 ...... in multiple myeloma patients.
@nl
type
label
Emerging roles of endoglin/CD1 ...... in multiple myeloma patients.
@en
Emerging roles of endoglin/CD1 ...... in multiple myeloma patients.
@nl
prefLabel
Emerging roles of endoglin/CD1 ...... in multiple myeloma patients.
@en
Emerging roles of endoglin/CD1 ...... in multiple myeloma patients.
@nl
P2093
P2860
P356
P1476
Emerging roles of endoglin/CD1 ...... in multiple myeloma patients.
@en
P2093
E Stavroulaki
F E Psarakis
G Tsirakis
M G Alexandrakis
V Bantouna
P2860
P304
P356
10.1002/HON.2044
P577
2013-04-11T00:00:00Z